by Haja Mo August 7, 2025 Business The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year. Previous Story How Ozempic Maker Novo Nordisk Lost Its Shine Next Story Southeast Asia Looks for Clarity From U.S. on ‘Rules of Origin’
